MedPath

Evaluation of The Effect of Melatonin in Thrombocytopenia

Phase 3
Conditions
Thrombocytopenia.
Thrombocytopenia, unspecified
D69.6
Registration Number
IRCT20080901001165N41
Lead Sponsor
Bagheiat-allah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Blood Platelets is less than 100,000 Per Microliter of Blood.
To sign the consent form knowingly.
At the same time,not in another clinical study.
The patient is between 18-65 years old.

Exclusion Criteria

The Patient is Pregnant.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood Platelet Count (Per Microliter of Blood). Timepoint: Before The Intervention and then Weekly for 12 Weeks. Method of measurement: Cell Blood Counter (CBC).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath